Related Experiment Video
Updated: Oct 18, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized
Tra My Pham1, Ian R White1, Brennan C Kahan1
1MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
Deriving composite endpoints from observed components can bias results, even with random missing data. Multiple imputation of missing components is the preferred method for accurate analysis in clinical trials.
Area of Science:
- Biostatistics
- Clinical Trials
- Epidemiology
Background:
- Composite endpoints are frequently used in randomized controlled trials.
- Partially observed components in composite endpoints complicate data analysis.
- Current methods for handling missing data include deriving the composite endpoint, complete record analysis (CRA), and multiple imputation (MI).
Purpose of the Study:
- To compare methods for analyzing composite endpoints with partially observed components.
- To evaluate the bias introduced by deriving composite endpoints.
- To determine the most appropriate method for handling missing data in composite endpoints.
Main Methods:
- Mathematical comparison of endpoint derivation, CRA, and MI.
- Simulation studies to assess method performance.
- Reanalysis of a published trial (TOPPS) using the compared methods.
Main Results:
- Deriving composite endpoints can lead to data missing not at random, even if components are missing completely at random.
- Treatment effect estimates from derived composite endpoints are biased.
- CRA results excluding participants with missing data are valid.
- MI of components is necessary for missing at random mechanisms.
Conclusions:
- Deriving composite endpoints from observed components is generally not recommended due to potential bias.
- Multiple imputation of missing components is the preferred approach for analyzing composite endpoints with missing data.
- While imputation models carry risks, MI offers a more robust solution compared to endpoint derivation.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Randomized Experiments
Simple randomization
Simple...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

